Law firm confirms validity of issuance in registered direct offering

Flangas Law Group provided a legal opinion confirming that China Pharma Holdings, Inc. can issue up to 2,500,000 shares in its registered direct offering. This filing supports the registration of the transaction under an existing SEC filing.